Canton Hathaway’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Canton Hathaway’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.05M	Hold	6,645	–	–	0.2%	62
2026 Q1	$849K	Hold	6,645	–	–	0.17%	66
2025 Q4	$810K	Hold	6,645	–	–	0.16%	66
2025 Q3	$666K	Sell	6,645 -450	-6%	-$40.5K	0.13%	78
2025 Q2	$588K	Sell	7,095 -1,750	-20%	-$140K	0.12%	81
2025 Q1	$717K	Sell	8,845 -8,415	-49%	-$752K	0.14%	66
2024 Q4	$1.55M	Sell	17,260 -1,685	-9%	-$163K	0.39%	34
2024 Q3	$1.87M	Buy	18,945 +1,310	+7%	+$129K	0.47%	29
2024 Q2	$1.64M	Buy	17,635 +4,060	+30%	+$364K	0.45%	32
2024 Q1	$1.29M	Buy	+13,575	New	+$1.26M	0.35%	37
2022 Q3	–	Sell	-300	Closed	-$22K	–	262
2022 Q2	$22K	Buy	+300	New	+$22.5K	0.01%	242
2022 Q1	–	Sell	-300	Closed	-$34K	–	296
2021 Q4	$34K	Sell	300 -50	-14%	-$6.03K	0.01%	226
2021 Q3	$44K	Hold	350	–	–	0.01%	195
2021 Q2	$47K	Hold	350	–	–	0.01%	166
2021 Q1	$47K	Hold	350	–	–	0.02%	165
2020 Q4	$49K	Hold	350	–	–	0.02%	169
2020 Q3	$39K	Hold	350	–	–	0.02%	241
2020 Q2	$39K	Hold	350	–	–	0.03%	114
2020 Q1	$27K	Hold	350	–	–	0.02%	117
2019 Q4	$33K	Hold	350	–	–	0.02%	147
2019 Q3	$27K	Hold	350	–	–	0.02%	157
2019 Q2	$31K	Hold	350	–	–	0.02%	151
2019 Q1	$31K	Hold	350	–	–	0.02%	152
2018 Q4	$25K	Hold	350	–	–	0.02%	133
2018 Q3	$34K	Buy	+350	New	+$33.9K	0.02%	114

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Canton Hathaway's XBI Position: Q2 2026 in Review

Canton Hathaway held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2026 at 6,645 shares worth $1.05M. The position accounts for 0.2% of the portfolio, ranked #62.

Canton Hathaway first reported a position in XBI in Q3 2018 and has held it in 25 quarters since. The position peaked at $1.87M in Q3 2024. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Canton Hathaway held 6,645 shares of State Street SPDR S&P Biotech ETF worth $1.05M as of Q2 2026.
Canton Hathaway left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2026.
State Street SPDR S&P Biotech ETF made up 0.2% of Canton Hathaway's portfolio in Q2 2026, its #62 holding.
Canton Hathaway first reported a position in State Street SPDR S&P Biotech ETF in Q3 2018 and has held it in 25 quarters since.
Canton Hathaway's State Street SPDR S&P Biotech ETF position peaked at $1.87M in Q3 2024.
933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Canton Hathaway's 13F filing for Q2 2026, filed 6 Aug 2026.